Transcriptome analysis revealed the genes and major pathways involved in prunetrin treated hepatocellular carcinoma (Hep3B cells)
The primary objective of the present investigation is to delineate the gene expression profile in liver cancer cells subjected to Prunetrin (PUR) treatment. Employing a comprehensive sequencing approach, the Illumina NextSeq550 platform was utilized to discern differentially expressed genes within the comparative contexts of control and PUR-treated conditions.